Skip to main content
NewslettersWatchlist

Latest

report on business
How Canadian bioplastic innovations are replenishing the planet
world
He Jiankui, scientist known for gene-editing babies, is out of prison and ready to rejoin the science community
In this Oct. 10, 2018 photo, He Jiankui, left, and Zhou Xiaoqin work a computer at a laboratory in Shenzhen in southern China's Guangdong province. Chinese scientist He claims he helped make world's first genetically edited babies: twin girls whose DNA he said he altered. He revealed it Monday, Nov. 26, in Hong Kong to one of the organizers of an international conference on gene editing. (AP Photo/Mark Schiefelbein)
international business
Musk’s Neuralink brain chip receives FDA tag to speed development of experimental implant aimed at restoring vision
FILE PHOTO: A smartphone with a Neuralink logo displayed is placed on a computer motherboard in this illustration taken on May 15, 2024. REUTERS/Dado Ruvic/Illustration/File Photo
the decibel: a daily news podcast from the globe and mail
Why AI is no miracle drug
Podcast
Podcast logo for The Decibel, the daily show from The Globe and Mail.
report on business
Sick Kids spinout Radiant developing ‘supercharged’ antibody drugs to target HIV, complex cancers
Researcher Jean-Philippe Julien, co-founder of Radiant Biotherapeutics, is seen in a lab atSickKids Peter Gilgan Centre for Research and Learning in Toronto, Thursday, September 12, 2024. Radiant Biotherapeutics has raised $35 million to develop super-antibody clusters in hopes of transforming therapies for patients facing complex diseases like HIV and cancer. (Galit Rodan/The Globe and Mail)
report on business
Revolution, interrupted: Why AI has failed to live up to the hype in drug development
Brendan Frey, co-founder of Deep Genomics, a biotechnology company focused on using AI in the service of genetic therapies, is seen in his office in Toronto, Monday, September 9, 2024. (Galit Rodan/The Globe and Mail) �
report on business
Bioceres genetically modified wheat can be grown safely, U.S. says
FILE PHOTO: Agricultural engineer Maximiliano Marzetti points to wheat seeds genetically modified with a strain called HB4, which has a gene that helps it better tolerate drought, inside a laboratory at Bioceres Crop Solutions in Rosario, Argentina July 19, 2022. REUTERS/Agustin Marcarian/File Photo
report on business
Ex-Chinook team launches Borealis Biosciences with $150-million from Novartis, Versant
(L-R) Jerel Davis of Versant Ventures, researcher Jim Ding and David Powell, Head of Research for Borealis Biosciences, chat at the Borealis Biosciences lab in Vancouver, B.C, on Wednesday, August 21, 2024. The new company, was launched from the team at Chinook, with funding from Versant capital. Tijana Martin/ The Globe and Mail�
world
Musk’s Neuralink says second trial implant went well, no thread retraction issue
FILE PHOTO: Neuralink logo and Elon Musk photo are seen in this illustration taken, December 19, 2022. REUTERS/Dado Ruvic/Illustration/File Photo
report on business
Bavarian Nordic to donate mpox vaccine doses following African emergency declaration
(FILES) This file photo taken on July 13, 2020 shows the company's logo on the headquarters of Danish biotechnology company Bavarian Nordic in Hellerup, north of Copenhagen. - Danish company Bavarian Nordic, the lone laboratory manufacturing a licensed vaccine against monkeypox, said on July 19, 2022 an "undisclosed European country" had ordered 1.5 million doses. The World Health Organization (WHO) has called for "intense" efforts to fight the disease as cases rise, especially in western Europe. (Photo by Liselotte Sabroe / Ritzau Scanpix / AFP) / Denmark OUT (Photo by LISELOTTE SABROE/Ritzau Scanpix/AFP via Getty Images)
number cruncher
Seven U.S. dividend-payers to weather turbulent markets
For Number Cruncher column in Globe Investor/ROB only.
international business
Japan’s Otsuka Pharma to pay up to $1.1-billion to acquire Jnana Therapeutics
A U.S. doctor displays a phenylketonuria test card. The practice has been criticized in the U.S. and Canada.
world
Meet some of the world’s cleanest pigs, raised to grow kidneys and hearts for humans
PIgs stand in pens at the Revivicor research farm near Blacksburg, Va., on May 29, 2024, where organs are retrieved for animal-to-human transplant experiments. (AP Photo/Shelby Lum)
report on business
Ticketmaster’s customer data hack, lie-detecting AI and the rise of super cheap online shopping
A new study says AI is better at detecting lies than humans, and polygraph tests.
report on business
AstraZeneca buys Hamilton-based smart cancer drug maker Fusion Pharmaceuticals for $2-billion
AstraZeneca said in a release the Fusion deal marks a “major step forward” in its ability to replace traditional cancer treatments like chemotherapy and radiotherapy with more targeted medicines that use molecules such as antibodies, peptides or small molecules to deliver nuclear isotopes to problematic cells. It will keep Fusion as a wholly-owned subsidiary with operations continuing in Canada and the U.S.
property report
Plans for a mass-timber building pivot to steel girders and concrete
A rendering of the exterior of the Leaside Innovation Centre. Originally planned for office space, which has been decreasing in demand since the start of the pandemic, it will now be designed to house wet labs. The new plans address the soaring need for lab space in Toronto’s burgeoning biotech sector, currently home to some 1,400 life sciences firms.
investment ideas
Deals, data buzz could help biotech shares exit Wall Street’s ‘no man’s land’
report on business
Field Trip Health raises largest financing in Canada for a psychedelics company
report on business
B.C.’s Eupraxia Pharmaceuticals sees lacklustre trading debut
advisor etfs
Why the nascent psychedelics industry is getting investors’ attention
Prev
123
Next

1 - 20 of 74 articles